Back

Association of left atrial strain with long-term cardiovascular mortality in hypertrophic cardiomyopathy

28 August 2023 (15:15 - 15:55)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy: clinical and prognostic value of imaging biomarkers Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sang-Chol Lee

Samsung Medical Center, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.
Doctor G. Todiere (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the left ventricular mass index by magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy
Doctor Q. Yang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Assessment of Myocardial Work in sarcomere gene mutation carriers and overt hypertrophic cardiomyopathy
Doctor C. Marques Pires (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Sex-related differences in the association between septal wall thickness and survival
Doctor S. Khoury (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Left atrial strain and long-term risk of atrial fibrillation in hypertrophic cardiomyopathy
Professor S. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy: clinical and prognostic value of imaging biomarkers

The Event

Event poster

ESC Congress 2023

28 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial dysfunction as a predictor of sudden cardiac death in hypertrophic cardiomyopathy: a strain-based analysis
thumbnail
Congress Presentation
Left atrial strain and long-term risk of atrial fibrillation in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Cardiac magnetic resonance-derived left atrial global longitudinal strain identifies low-risk patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources